FLAURA研究OS阳性结果——奥希替尼一线治疗晚期EGFR敏感突变非小细胞肺癌

    Overall Survival of Osimertinib in Untreated Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation

    /

    返回文章
    返回